Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Mills

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Theranostics|May 19, 2018
Plectin-targeted liposomes enhance the therapeutic efficacy of a PARP inhibitor in the treatment of ovarian cancerSiva Sai Krishna Dasa, Galina Diakova, Ryo Suzuki, et al.
Cancer Chemotherapy and Pharmacology|December 12, 2018
A window-of-opportunity clinical trial of dasatinib in women with newly diagnosed endometrial cancerLinda R Duska, Gina R Petroni, Heather Lothamer, et al.
JMIR Medical Education|July 25, 2018
Expanding Opportunities for Professional Development: Utilization of Twitter by Early Career Women in Academic Medicine and ScienceJaime D Lewis, Kathleen E Fane, Angela M Ingraham, et al.
The American Journal of Surgical Pathology|February 15, 2017
PD-L1 Expression and Intratumoral Heterogeneity Across Breast Cancer Subtypes and Stages: An Assessment of 245 Primary and 40 Metastatic TumorsErik A Dill, Alejandro A Gru, Kristen A Atkins, et al.
The American Journal of Surgical Pathology|March 18, 2011
Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistryAnne M Mills, Andrew H Beck, Kelli D Montgomery, et al.
Oncotarget|March 7, 2018
Evaluation of SAS1B as a target for antibody-drug conjugate therapy in the treatment of pancreatic cancerKiley A Knapp, Eusebio S Pires, Sara J Adair, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|November 25, 2025
Mesonephric-like Adenocarcinoma (MLA) Diagnostic Criteria and Controversies: Perspectives and Guidance From Pathologists in the MLA ConsortiumAnne M Mills, Elizabeth D Euscher, W Glenn McCluggage, et al.
The American Journal of Surgical Pathology|May 23, 2024
Molecular Classification Outperforms Histologic Classification in Prognostication of High-grade Endometrial Carcinomas With Undifferentiated and Sarcomatous ComponentsPhoebe M Hammer, Aihui Wang, Lisa Vermij, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 17, 2019
Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasmsSabrina Croce, Isabelle Hostein, Teri A Longacre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2023
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists GuidelinePraveen Vikas, Hans Messersmith, Carolyn Compton, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Theranostics|May 19, 2018
Plectin-targeted liposomes enhance the therapeutic efficacy of a PARP inhibitor in the treatment of ovarian cancerSiva Sai Krishna Dasa, Galina Diakova, Ryo Suzuki, et al.
Cancer Chemotherapy and Pharmacology|December 12, 2018
A window-of-opportunity clinical trial of dasatinib in women with newly diagnosed endometrial cancerLinda R Duska, Gina R Petroni, Heather Lothamer, et al.
JMIR Medical Education|July 25, 2018
Expanding Opportunities for Professional Development: Utilization of Twitter by Early Career Women in Academic Medicine and ScienceJaime D Lewis, Kathleen E Fane, Angela M Ingraham, et al.
The American Journal of Surgical Pathology|February 15, 2017
PD-L1 Expression and Intratumoral Heterogeneity Across Breast Cancer Subtypes and Stages: An Assessment of 245 Primary and 40 Metastatic TumorsErik A Dill, Alejandro A Gru, Kristen A Atkins, et al.
The American Journal of Surgical Pathology|March 18, 2011
Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistryAnne M Mills, Andrew H Beck, Kelli D Montgomery, et al.
Oncotarget|March 7, 2018
Evaluation of SAS1B as a target for antibody-drug conjugate therapy in the treatment of pancreatic cancerKiley A Knapp, Eusebio S Pires, Sara J Adair, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|November 25, 2025
Mesonephric-like Adenocarcinoma (MLA) Diagnostic Criteria and Controversies: Perspectives and Guidance From Pathologists in the MLA ConsortiumAnne M Mills, Elizabeth D Euscher, W Glenn McCluggage, et al.
The American Journal of Surgical Pathology|May 23, 2024
Molecular Classification Outperforms Histologic Classification in Prognostication of High-grade Endometrial Carcinomas With Undifferentiated and Sarcomatous ComponentsPhoebe M Hammer, Aihui Wang, Lisa Vermij, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 17, 2019
Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasmsSabrina Croce, Isabelle Hostein, Teri A Longacre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2023
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists GuidelinePraveen Vikas, Hans Messersmith, Carolyn Compton, et al.
Pageof 11